Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Harvard University · Center for Systems Biology
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
660
total citations
- FWCI
- 53.53
- Percentile
- 100%
- References
- 58
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Drug
- Drug action
- Clinical trial
- Drug resistance
- Biology
- Combination therapy
- Pharmacology
- Mechanism (biology)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.